Semen allii tuberosi total saponin, preparation method and application thereof in preparation of medicine for treating nephrotic syndrome
By optimizing the extraction and purification process of total saponins of leek seeds, the differences in the effects and side effects of treating nephrotic syndrome in the prior art were solved, and efficient nephrotic syndrome treatment was achieved, which significantly improved the content and purity of total saponins of leek seeds and alleviated the relief of total saponins of leek seeds. Proteinuria and antioxidant function that protects the kidneys.
Patent Information
- Application Number
- CN202410989451.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-23
AI Technical Summary
The prior art has differences in therapeutic effects and side effects in the treatment of nephrotic syndrome, and lacks effective drugs. The application of leek seeds in this field has not been reported in literature.
The extraction and purification process of total saponin of chive seed was optimized by single-factor experiments and response surface method. Through ethanol extraction, water dissolution, adsorption resin purification and organic solvent extraction, the content and purity of total saponin of chive seed were improved, and purity of total saponin of chive seed was used to treat nephrotic syndrome.
It significantly shortens the extraction time of total saponin of chive seeds, increases its content, and provides a cost-effective treatment for nephrotic syndrome. The total saponin of chive seeds can relieve proteinuria, improve serum albumin levels, reduce blood lipids and urea nitrogen, and protect Kidney, significantly improves antioxidant function.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of plant extraction, and in particular relates to a total saponin of leek seeds, a preparation and purification method thereof, and a new application thereof in preparing a medicine for treating nephrotic syndrome and a health product. Background Art
[0002] Entering the 21st century, due to people's living habits and dietary preferences, the clinical incidence of kidney diseases has increased year by year, especially nephrotic syndrome, which seriously endangers human life, health and quality of life. Nephrotic syndrome is characterized by severe leakage of proteinuria, hyperlipidemia, hypoproteinemia and external skin edema, the so-called "three highs and one low", and a group of clinical syndromes characterized by other metabolic disorders. Nephrotic syndrome is usually caused by glomerular damage. When blood passes through the kidneys, the glomeruli filter the blood and separate what the body needs from what it does not need. Healthy glomeruli can maintain the required protein content in the body. When the glomeruli are damaged, too much blood protein will be allowed to penetrate into the urine, leading to nephrotic syndrome. Large amounts of proteinuria are the most important clinical manifestation and the most basic pathophysiological mechanism of nephrotic syndrome. Nephrotic syndrome is clinically common and difficult to treat. Patients will experience abnormal platelets, hemoconcentration, and a large loss of anticoagulants, which will lead to complications such as thrombosis, which seriously threatens human health. At present, the clinical treatment of this disease is mainly glucocorticoids and diuretics. However, the therapeutic effects of these drugs generally vary and have side effects in different patient groups. Therefore, it is of great significance to explore new potential effective drugs for the treatment of nephrotic syndrome. At present, there are no literature reports on the application of leek seeds in the treatment of nephrotic syndrome.
[0003] Leek seeds (Semen Allii Tuberose) are the dried mature seeds of the perennial plant Allium tuberosum Rottl.Ex Spreng. of the genus Allium of the Liliaceae family. The history of leek seeds as medicine can be traced back to the Spring and Autumn Period and the Warring States Period. The records of herbal medicine were first seen in "Famous Doctors' Records" and were listed as medium-grade products. They have the effects of warming the kidney and assisting yang, consolidating essence, and are commonly used for spermatorrhea, frequent urination, enuresis, and other prostration diseases. Studies have shown that the chemical components of leek seeds mainly include compounds such as steroidal saponins, alkaloids, sulfides, and flavonoids. Modern pharmacological studies have shown that leek seeds have the effects of strengthening yang, enhancing immunity, anti-oxidation, anti-aging, and antibacterial. Since the leek planting area is widely distributed throughout the country, leek seeds, as a subsidiary product of leek production, are in sufficient supply, so that their prices have been kept at a stable and reasonable stage. It is of great significance to develop a cheap and efficient medicine or health product for the treatment of nephrotic syndrome. Based on this, this application has been developed. Summary of the invention
[0004] The invention aims to overcome the defects of the prior art and provide a total saponin of leek seeds, which can be used to treat nephrotic syndrome with significant curative effect.
[0005] In order to optimize the extraction and purification method of total saponins in leek seeds and increase the content thereof, the present invention provides a method for extracting and purifying total saponins in leek seeds optimized by single factor experiment and response surface methodology.
[0006] The present invention also provides a new application of the leek seed total saponin in preparing medicines and health products for treating nephrotic syndrome.
[0007] To achieve the above object, the present invention adopts the following technical solution:
[0008] A preparation method of leek seed total saponin comprises the following steps: adding leek seeds into ethanol for extraction, and concentrating under reduced pressure after the extraction to obtain a crude extract; dissolving the crude extract in water, adsorbing it on a macroporous adsorption resin, and then eluting it with water and ethanol, collecting the ethanol eluate, and concentrating it under reduced pressure to obtain component 1; dissolving component 1 in water, extracting with an organic solvent, and concentrating the aqueous phase obtained by extraction under reduced pressure and drying to obtain leek seed total saponin.
[0009] Specifically, the leek seeds can be added to ethanol with a volume concentration of 5-90% for extraction, and the extraction is performed 1-5 times for 60-120 seconds. Furthermore, the volume concentration of ethanol is preferably 10-40%.
[0010] Specifically, the crude extract was dissolved in water and then adsorbed on HPD100 macroporous adsorption resin for 8-15 hours.
[0011] Specifically, 60-80% ethanol by volume can be used for elution. More preferably, 2-4 BV column volumes of 65-75% ethanol are used for elution at a rate of 0.4-1 BV / h.
[0012] Specifically, the organic solvent used in the extraction can be ethyl acetate or the like.
[0013] The invention provides leek seed total saponin prepared by the preparation method.
[0014] The present invention also provides the use of the total saponins of leek seeds in preparing medicines or health products for treating nephrotic syndrome, especially in preparing medicines or health products for treating nephrotic syndrome caused by adriamycin.
[0015] Furthermore, the present invention also provides the use of the above-mentioned leek seed total saponin in the preparation of a medicine or health product for protecting kidney tissue from oxidative damage.
[0016] In the present invention, the solid-liquid ratio of 1g:10mL is used as a fixed factor for flash extraction. A single factor experiment is used to determine the effects of the ethanol concentration required for extraction, the extraction time and the number of extractions on the quality of the total saponin extraction of leek seeds, and the steps are as follows: in the single factor experiment, 0%-95% ethanol is added to the crushed leek seeds according to a solid-liquid ratio of 1:10 for flash extraction, 1-5 extractions, and an extraction time of 60-120s for investigation.
[0017] Preferably, the single factor experiment optimizes the flash extraction process conditions of total saponins from leek seeds as follows: 20% ethanol, 3 extraction times, and 105 s extraction time.
[0018] When conducting a three-factor three-level response surface design for the total saponins of leek seeds, the optimal extraction conditions optimized by single factor were taken as the central value, and the total saponins quality of leek seeds was taken as the response value. The quadratic multiple regression equation model established in the response surface is:
[0019] Y=7.79-0.3869A-0.2020B-0.4004C-0.0373AB-0.3449AC+0.2258BC-1.49A 2 -1.27B 2 -1.19C 2 ,
[0020] Where Y is the mass of saponin (mg), A is the ethanol concentration, B is the number of extractions, and C is the flash extraction time.
[0021] The extract obtained by the optimal factor extraction of the response surface is passed through a macroporous resin (preferably, the model of the macroporous adsorption resin is HPD100, and the loading solution concentration is 12 mg / mL), and eluted with 2-3 BV times column volume of 70% ethanol at a speed of 0.5 BV / h, the fractions are combined, concentrated under reduced pressure to recover the solvent, dried, and then re-dissolved with water and extracted with ethyl acetate in a 1:1 (volume: volume) ratio. The aqueous phase obtained by the extraction is concentrated again and dried to obtain the final leek seed total saponins.
[0022] The optimal process of the extraction process response surface is: ethanol concentration 19.052%, extraction times 2.97 times, extraction time 104.569s. In order to facilitate the actual operation, the optimal conditions were adjusted to: ethanol concentration 20%, extraction times 3 times, extraction time 105s, and the total saponin content in the obtained crude extract was 1.95%. The crude extract was purified by macroporous resin HPD100, eluted with 70% ethanol and extracted with ethyl acetate to obtain the final total saponin of leek seeds, with a total saponin content of 54-58%.
[0023] The present application discloses an optimized extraction and purification process of total saponins of leek seeds, which uses single factor and response surface methods to optimize the extraction method of total saponins of leek seeds, and then purifies it, and studies the pharmacological activity of the final product in treating nephrotic syndrome. The experimental results show that total saponins of leek seeds can alleviate proteinuria in nephrotic syndrome mouse models, increase serum albumin levels, reduce serum low-density lipoprotein (LDL-C), blood creatinine (CR), total cholesterol (T-CHO), triglycerides (TG), blood urea nitrogen (BUN) levels and kidney Podocin protein expression, and improve renal tissue pathological changes. The medium and high dose groups of total saponins of leek seeds can significantly reduce the MDA content in the kidneys of mice after doxorubicin administration, and significantly increase the activity of T-SOD enzyme.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] 1) The present invention provides total saponins of leek seeds prepared by the above method, which can greatly shorten the extraction time of total saponins of leek seeds and is an economical and efficient method for preparing total saponins of leek seeds, wherein the content of total steroidal saponin compounds is >54%.
[0026] 2) The present invention also provides the use of the above-mentioned leek seed total saponins in treating nephrotic syndrome, especially in treating nephrotic syndrome caused by doxorubicin.
[0027] 3) The present invention has found through experiments that the total saponins of leek seeds have a significant therapeutic effect on adriamycin-induced mouse nephropathy, and its protective mechanism may be related to enhancing the antioxidant function of mouse kidneys. Therefore, the present invention also provides the use of the above-mentioned total saponins of leek seeds in the preparation of drugs or health products for treating nephrotic syndrome.
[0028] 4) The present invention extracts total steroidal saponins from leek seeds, and adopts tail vein injection of adriamycin to induce nephrotic syndrome mouse model. Experimental studies have found that: leek seed total saponins can alleviate the kidney damage of mice caused by adriamycin, and have a certain protective effect, which is manifested as reducing glomerular sclerosis, alleviating mesangial cell increase and diffuse proliferation of mesangial matrix, and reducing the degree of vascular fibrosis around the glomerulus. It has the effect of reducing urine protein and BUN, CR, T-CHO, LDL-C, and TG in serum, and can reduce the MDA content in mouse kidneys; increase the levels of SOD, Podocin in the kidneys and albumin in the serum, indicating that the leek seed total saponins of the present invention have the effect of alleviating kidney damage in nephrotic syndrome mice, enhancing renal function and antioxidant capacity. In addition, the preparation method of the leek seed total saponins of the present invention is simple, the extract has a high purity, and the leek seeds are widely available and convenient to obtain, while opening up the use of leek seed total saponins for the treatment of nephrotic syndrome drugs or health products. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 is the standard curve of protodioscin;
[0031] Figure 2 The effects of ethanol concentration (left), extraction times (middle), and extraction time (right) on the quality of total saponins in leek seeds;
[0032] Figure 3 This is the response surface diagram of the extraction process of total saponins from leek seeds. 3D response surface diagram of ethanol concentration (upper left), response surface contour diagram of ethanol concentration (lower left); 3D response surface diagram of extraction times (upper middle), response surface contour diagram of extraction times (lower middle); 3D response surface diagram of extraction time (upper right), response surface contour diagram of extraction time (lower right);
[0033] Figure 4 Liquid-mass spectrometry for the identification of total saponin components in leek seeds, positive ion spectrum (upper) and negative ion spectrum (lower);
[0034] Figure 5 The effect of total saponins from leek seeds on urine protein content, compared with the blank group, ###P<0.001; compared with the model group, *P<0.05, **P<0.01, ***P<0.001;
[0035] Figure 6 The effect of total saponins of leek seeds on serum albumin content (left), low-density lipoprotein content (middle), and serum creatinine content (right). Compared with the blank group, ###P<0.001; compared with the model group, **P<0.01, ***P<0.001;
[0036] Figure 7 The effect of total saponins from leek seeds on total cholesterol content (left), triglyceride content (middle), and blood urea nitrogen content (right). Compared with the blank group, ###P<0.001; compared with the model group, **P<0.01, ***P<0.001;
[0037] Figure 8 PAS staining and HE staining of kidney pathological sections;
[0038] Fig. 9 The total saponins of leek seeds affect the expression of Podocin protein in the kidney tissue of mice with nephrotic syndrome, Podocin protein band diagram (left), Podocin protein quantitative analysis diagram (right), compared with the blank group, ###P<0.001; compared with the model group, *P<0.05, ***P<0.001;
[0039] Fig.10Effects of total saponins from leek seeds on MDA level (left) and T-SOD activity (right) in renal tissue of mice with nephrotic syndrome. Compared with the normal group, ##P<0.01, ###P<0.001; compared with the model group, *P<0.05, **P<0.01, ***P<0.001. DETAILED DESCRIPTION
[0040] The technical solution of the present invention is further described in detail below in conjunction with the embodiments, but the protection scope of the present invention is not limited thereto.
[0041] In the following examples, unless otherwise specified, the raw materials used are common commercial products that can be directly purchased or can be prepared using conventional techniques in the art.
[0042] Room temperature refers to 25±5°C.
[0043] Example 1
[0044] Optimization of extraction process of total saponins from leek seeds
[0045] 1. Drawing of the standard curve of protodioscin
[0046] The total saponins in leek seeds contain protodioscin, the content of which is not low (see Table 5 and Figure 4 ), and its structure is similar to other saponins, so protodioscin is used as a reference substance, and 1 mL of protodioscin solution is accurately drawn with a pipette to prepare 0.05 mg / mL, 0.20 mg / mL, 0.35 mg / mL, 0.50 mg / mL and 0.65 mg / mL, respectively, and placed in a clean 25 mL round-bottom flask. Vacuum rotary evaporation at 70°C until dry, quickly and accurately add 0.8 mL of perchloric acid and 0.2 mL of 5% vanillin-glacial acetic acid (0.5 g of vanillin is diluted to 10 mL with glacial acetic acid, 10 mL volumetric flask) with a pipette, and make a blank sample at the same time. All are placed in a 60°C water bath for color development for 15 minutes, and then the flask is quickly cooled with running water for 5 minutes. Add 5 mL of glacial acetic acid and shake evenly, immediately measure the absorbance at 454 nm, record the data, and draw a standard curve with absorbance as the ordinate and concentration as the abscissa, as shown Figure 1 As shown: y = 1.609x-0.0436, R 2 =0.9995.
[0047] 2. Determination of the quality of total saponins in leek seeds
[0048] The crude extract obtained under the optimal conditions of the single-factor extraction experiment was prepared into 50 mL of an extract solution with a concentration of 20 mg / mL. 1 mL of the solution was taken for colorimetric reaction using the colorimetric method in Example 1, and the absorbance of the crude extract solution of leek seed saponins was determined by the colorimetric method. (Three replicates) The total saponin concentration in the crude extract of the corresponding concentration was calculated using the standard curve, and the saponin mass and saponin content were calculated by substituting into the following formula ① and formula ②. The formula is as follows:
[0049] M=CVn①
[0050]
[0051] Wherein: M represents the mass of saponin (mg / g); Y represents the content of saponin (%); C represents the concentration of total saponins in the extract (mg / mL); V represents the volume of the test solution (mL); n represents the dilution multiple from the test solution to the test solution; m represents the mass of the crude extract powder weighed (mg).
[0052] 3. Single factor experimental method and results
[0053] The single factor experiment was conducted by selecting ethanol concentration, extraction time and extraction times to obtain the relationship between each factor and the quality of total saponins in leek seeds.
[0054] (1) Effect of ethanol concentration of extract on saponin quality
[0055] The solid-liquid ratio was fixed at 1 g: 10 mL, the number of extractions was 3, the extraction time was 90 s, and the total saponin mass was determined at 0%, 20%, 35%, 50%, 65%, 80%, and 95% ethanol volume concentrations. The results are shown in Figure 2 .from Figure 2 It can be seen that when water extraction and 20% ethanol extraction were performed, the saponin content increased continuously and then gradually decreased, so it is believed that the extraction is best when the volume fraction of ethanol is 20%.
[0056] (2) Effect of extraction time on saponin quality
[0057] The ethanol concentration was fixed at 20%, the solid-liquid ratio was 1 g: 10 mL, the extraction times were 3 times, and the total saponin mass in the solution was measured at extraction times of 60 s, 75 s, 90 s, 105 s, and 120 s, respectively. The results are shown in Figure 2 .from Figure 2 It can be seen that the quality of saponins increases with the extension of extraction time. When the extraction time is 105s, the quality of saponins obtained is the highest, and it gradually decreases from 105s to 120s. Therefore, 105s is taken as the optimal extraction time.
[0058] (3) Effect of extraction times on saponin quality
[0059] The ethanol concentration was fixed at 20%, the solid-liquid ratio was 1 g: 10 mL, and the extraction time was 105 s. The total saponin mass in the solution was determined at 1, 2, 3, 4, and 5 extraction times. The results are shown in Table 1. Figure 2 . Figure 2 The results showed that the best extraction effect was achieved when the extraction times were 3 times.
[0060] 4. Optimization of extraction conditions by response surface methodology
[0061] (1) Response surface experimental design
[0062] According to the results of the single factor test, a response surface optimization experiment was further designed. The factor level with the best total saponin extraction effect was selected, and the ethanol concentration, extraction times, and extraction time were used as independent variables, and the quality of extracted saponins was used as the response value. A 3-factor 3-level Box-Behnken Design experiment was adopted, and each experiment was repeated 3 times. The specific implementation methods are shown in Tables 1 and 2.
[0063] Table 1 Factors and levels of single factor experiment
[0064]
[0065] Table 2 Box-Behnken experimental scheme and total saponin quality of leek seeds
[0066]
[0067]
[0068] (2) Regression model establishment and variance analysis
[0069] The results of Box-Behnken response surface design are shown in the table above. Design-Expert 13.0 software was used to perform quadratic multiple regression fitting on each factor, and the binomial multiple regression model equation for saponin quality (Y) was obtained:
[0070] Y=7.79-0.3869A-0.2020B-0.4004C-0.0373AB-0.3449AC+0.2258BC-1.49A 2 -1.27B 2 -1.19C 2 ,
[0071] R 2 =0.9985, R 2 adj=0.9967, that is, the equation can explain 99.67% of the experimental data variation, the regression model P < 0.05, with significant difference; the difference in the level of lack of fit is not significant (P > 0.05), indicating that the model has a good fit, and factors A, B, C, BC, AC have a significant effect, which can be analyzed by a mathematical model. In the formula: Y is the mass of saponin, A is the ethanol concentration, B is the number of extractions, and C is the extraction time.
[0072] 3D response surface analysis of the extraction process of total saponins from leek seeds Figure 3 As shown. The response surface plots drawn according to the quadratic regression equation are all convex surfaces with an opening downward, indicating that there is a maximum response value within the scope of investigation. The shape of the contour lines can reflect the strength of the interaction between the influencing factors. When the contour lines are closer to a circle, the interaction between the two factors is weaker. When the contour lines are elliptical, the interaction between the two factors is strong. Figure 3 It can be seen that the three factors of ethanol concentration, extraction times and extraction time all have a certain influence on the extraction of total saponins from leek seeds. The ethanol concentration and extraction time, extraction time and extraction times reflect a certain degree of interaction, and the interaction between ethanol concentration and extraction times is weak.
[0073] Table 3 Analysis of variance of regression model
[0074]
[0075]
[0076] Note: P>0.05 indicates no significant difference; P<0.05 indicates significant difference; P<0.01 indicates extremely significant difference.
[0077] (3) Verification test
[0078] According to the optimal process conditions predicted by the response surface and the specific experimental steps, the optimized process parameters were adjusted to: ethanol concentration 20%, extraction times 3 times, extraction time 105s, and three parallel experiments were carried out under the optimal conditions. Each group weighed 10g of leek seeds for verification, and the results were shown in Table 4. The three parallel experiments were similar to the results predicted by the model, which was suitable for the extraction of total saponins from leek seeds.
[0079] Table 4 Verification test results
[0080]
[0081] Example 2
[0082] A process for extracting and purifying total saponins from leek seeds, comprising the following specific steps:
[0083] Take 1kg of leek seeds, the extraction conditions are: add 70% ethanol at a solid-liquid ratio of 1g:10mL, flash extraction at room temperature, extract 3 times, 105s each time, combine the three extracts after the flash extraction and concentrate under reduced pressure to obtain 121.9g of crude extract. The crude extract is dissolved in water to prepare a 12mg / mL aqueous solution, adsorbed overnight (12h) by HPD100 macroporous adsorption resin, and then rinsed with water until the effluent is colorless (discarded); then eluted with 2.5BV column volume 70% ethanol at a speed of 1BV / h, combined and collected eluents, recovered solvents by reduced pressure concentration, and dried to obtain 12.3g of component 1. Component 1 was dissolved in water and extracted with ethyl acetate at 1:1 (volume ratio). The aqueous phase obtained by extraction was concentrated under reduced pressure and dried to obtain 5.5g of total saponins from leek seeds. The total saponins content of leek seeds was 54.42% as measured by spectrophotometry.
[0084] The total ion chromatogram of total saponins from leek seeds is shown in Figure 4 , 22 saponin components were detected in the positive ion chromatogram, and 10 saponin components were detected in the negative ion chromatogram. The specific compound names, molecular formulas, retention times, and mass spectrum information are shown in Tables 5 and 6. A total of 32 saponin components were identified.
[0085] Table 5 Identification table of positive ions of total saponin components in leek seeds
[0086]
[0087]
[0088] Table 6 Identification table of negative ions of total saponin components in leek seeds
[0089]
[0090]
[0091] Example 3
[0092] A process for extracting and purifying total saponins from leek seeds, comprising the following specific steps:
[0093] Take 10 g of Chinese chive seeds, and the extraction conditions are as follows: Add 70% ethanol at a solid-liquid ratio of 1 g:10 mL and perform flash extraction at room temperature for 3 times, 105 s each time. After the flash extraction, combine the three extracts and concentrate them under reduced pressure to obtain 1.08 g of crude extract. Dissolve the crude extract in water to prepare a 12 mg / mL aqueous solution, adsorb it on HPD100 macroporous adsorption resin overnight (12 h), and then wash it with water until the effluent is colorless (discarded); then elute it with 3 column volumes (BV) of 70% ethanol at a speed of 0.5 BV / h, combine the collected eluate, concentrate it under reduced pressure to recover the solvent, and dry it to obtain 0.17 g of component 1. Dissolve component 1 in water and perform extraction with ethyl acetate at a volume ratio of 1:1. The aqueous phase obtained by extraction is concentrated under reduced pressure and dried to obtain 76.8 mg of total saponins from Chinese chive seeds. The content of total saponins from Chinese chive seeds is measured by spectrophotometry to be 57.43%.
[0094] Effect experiment 1: Therapeutic effect of total saponins from Chinese chive seeds on adriamycin-induced nephrotic syndrome in mice.
[0095] Experimental raw materials: The total saponins from Chinese chive seeds prepared in Example 2 are used as experimental raw materials.
[0096] Experimental animals: Balb / c mice, weighing 18 - 22 g, SPF grade, provided by Henan Experimental Animal Center, production batch number: SCXK(Yu)2020 - 0005.
[0097] Experimental reagents: See Table 7 below.
[0098] Experimental instruments: See Table 8 below.
[0099] Table 7. Experimental reagents
[0100]
[0101]
[0102] Table 8. Experimental instruments
[0103]
[0104]
[0105] Experimental method:
[0106] Male Balb / c mice were adaptively raised for one week, and the mice were photographed and observed for fur color after weighing. Then the mice were placed in metabolic cages to collect 24h urine (fasting but not water) and the volume was accurately recorded. The urine was centrifuged at 4℃, 3500r for 15min, and the supernatant was collected. The 24h urine protein of mice was detected by urine protein detection kit to determine that all mice were normal mice. All mice were divided into blank group (n=15) and model group (n=75). Except for the blank group, the mice in the other model groups were injected with 10mg / kg of doxorubicin through the tail vein to construct the doxorubicin nephropathy model. The blank group was injected with the same dose of normal saline through the tail vein as a control. After 7 days of injection of doxorubicin, the blank group and model group mice were photographed and observed for fur color. Then the blank group and model group mice were collected with metabolic cages for 24h urine (fasting but not water), and the volume was accurately recorded. The urine was centrifuged at 4℃, 3500r for 15min, and the supernatant was collected. The 24h urine protein content was detected by the kit. The mice in the model group with urine protein content ≥50 mg / kg were included in the subsequent experiments.
[0107] The blank group and the mice with successful modeling were divided into a blank group (n=15), a model group (n=15), a positive drug group (n=15), a low-dose group (n=15), a medium-dose group (n=15) and a high-dose group (n=15). After grouping, each group was gavaged every day. The blank group and the model group were gavaged with 10g / 0.1mL of normal saline every day, the positive drug group was gavaged with 10mg / kg prednisolone acetate in normal saline, and the low, medium and high dose groups were gavaged with 20mg / kg, 40mg / kg and 80mg / kg of leek seed total saponins in normal saline, respectively. Urine test: The urine protein of each group of mice was tested with the Elabscience urine protein colorimetric test kit on the 7th, 14th, 21st, 28th, 35th and 42nd day of the experiment, and the operation steps were strictly in accordance with the instructions of the kit. Blood test: The collected serum samples were tested for albumin, low-density lipoprotein, blood urea nitrogen, blood creatinine, total cholesterol and triglycerides. The above indicators were tested using Nanjing Jiancheng Biochemical Detection Kit, and the operation steps were strictly in accordance with the instructions of the kit. Graphpad Prism 6 statistical software was used for processing and analysis, and the results were displayed in bar graphs. P<0.05 was considered statistically significant. The results are shown in Figure 4 , 5 and 6.
[0108] After blood was drawn, the mice were killed by dissection of the neck, and the kidneys and liver were removed and rinsed with saline. Finally, the right kidney tissue was placed in a 4% paraformaldehyde solution for 20-24 hours. The tissue was trimmed into a thickness of about 5 mm with a blade in a sterile experimental environment. The tissue was placed in a dehydration box in turn, and then dehydrated, embedded, sliced, baked, PAS stained and HE stained, examined under a microscope, and imaged and analyzed. The results are shown in Figure 7 .
[0109] Weigh the kidneys of mice in the blank group, model group, medium-dose group and high-dose group, add 1mL of the high-efficiency RIPA lysis buffer (containing 1% PMSF) and 0.01mL of protein phosphatase inhibitor prepared in advance, grind at low temperature, place the tissue grinding homogenate on ice for 30min, centrifuge at 4℃ and 12000rpm for 10min, and take the supernatant. Use the BCA protein concentration determination kit for protein quantification (specific operation according to the instructions). Add an appropriate amount of protein loading buffer ((the buffer provided by the BCA protein concentration determination kit)) to the supernatant and mix well, boil and denature for 10min, cool in an ice bath for aliquoting, and take out an appropriate amount of protein sample for SDS-PAGE gel electrophoresis. The concentrated gel is kept at a constant voltage of 80V for about 30-40 minutes; the separation gel is kept at a constant voltage of 120V until the pre-stained protein Maker (bromophenol blue) runs to the bottom, and the electrophoresis is stopped. Gel-PVDF transfer, 5% skim milk powder blocking solution, placed on a shaker, 80prm / min, room temperature blocking for 2h. Podocin and GAPDH (1:1000, volume ratio) primary antibody were incubated at 4℃ overnight, about 13-15h. Goat anti-rabbit IgG (H+L) HRP, 1:30000, incubated at room temperature for 2h. 100 μl of ECL supersensitive luminescent liquid was added, developed on the Western blot imaging system, and grayscale value analysis of protein strips was performed using Image J. Results are shown in Figure 8 .
[0110] In the above experimental process, the experimental operations, conditions, etc. that are not mentioned or recorded in detail can be adopted by conventional techniques in the field. Since they are not the innovation of the present application, they will not be described in detail.
[0111] Experimental results:
[0112] Figure 5 , 6 7 shows the changes of biochemical indexes of nephrotic syndrome in mice induced by adriamycin by the total saponins of leek seeds of the present invention. Figure 5 is the urine protein content; Figure 6 Serum albumin level, low-density lipoprotein level, and blood creatinine level; Figure 7 It is the total cholesterol content, triglyceride content, and blood urea nitrogen content. Figure 5 , 67 It can be seen that the total saponins of leek seeds can significantly alleviate the proteinuria of mice, increase the level of serum albumin, and reduce the content of serum low-density lipoprotein (LDL-C), serum creatinine (CR), total cholesterol (T-CHO), triglycerides (TG), and blood urea nitrogen (BUN). The above results show that the medium and high dose groups of the total saponins of leek seeds of the present invention have a significant therapeutic effect on improving the nephrotic syndrome of mice caused by adriamycin, and the medium dose group has the best therapeutic effect.
[0113] Figure 8 The effect of the total saponins of leek seeds on the pathological changes of renal tissue in mice with nephrotic syndrome induced by adriamycin (kidney PAS staining and HE staining pathological sections). Figure 7 It can be seen that the glomerular morphology of the blank group is complete, no mesangial hyperplasia and glomerular sclerosis, no pathological characteristics such as balloon adhesion and inflammatory cell infiltration occur, the cytoplasm is uniform, the glomerular capillary cavity is open, and the cell morphology is normal overall; the model group has obvious glomerular sclerosis, widening of the mesangial area, and deposition of extracellular matrix in the mesangial area, and balloon adhesion and inflammatory cell infiltration are locally visible. The middle and high dose groups of the total saponins of allium seeds of the present invention have normal glomerular morphology on the whole, no pathological phenomena such as glomerular sclerosis, balloon adhesion, mesangial cell hyperplasia, diffuse proliferation of mesangial matrix, etc., the glomerular capillary cavity is clearly visible, no or less inflammatory cell infiltration, and the cytoplasm is uniform.
[0114] Fig. 9 The effect of leek seed total saponins on the expression of Podocin protein in the kidney tissue of mice with nephrotic syndrome is given. Podocin is a transmembrane protein of podocytes in the glomerulus. Changes in Podocin affect the changes in the foot processes of podocytes and the integrity of the slit diaphragm, affecting the filtration function of the glomerulus. Nephropathy is closely related to the Podocin protein in podocytes. Figure 8 It can be seen that compared with the blank group, the Podocin level in the model group was significantly reduced. The medium and high doses of the total saponins of leek seeds of the present invention can significantly increase the Podocin level in the kidney, indicating that the treatment of total saponins of leek seeds has a certain protective effect on glomerular podocytes and can alleviate the renal podocyte damage caused by ADR.
[0115] Effect experiment 2: Antioxidant test of total saponins from leek seeds
[0116] Experimental materials: Same as effect experiment 1.
[0117] Experimental animals: Same as effect experiment 1.
[0118] Experimental reagents: See Table 9 below.
[0119] Experimental instruments: See Table 10 below.
[0120] Table 9 Experimental reagents
[0121]
[0122] Table 10 Experimental instruments
[0123]
[0124] Experimental method: The animal experiment was the same as the effect experiment 1. The kit experimental operation was carried out according to the kit instructions. The kidney tissue was ground into a homogenate with physiological saline, and the homogenate was centrifuged at 4°C, 3500r / min, and 10min. The supernatant was taken for the experiment. The MDA content and T-SOD enzyme activity of the mouse kidney tissue were measured.
[0125] Fig.10 The effects of total saponins from leek seeds on MDA and T-SOD enzymes in the kidney tissue of mice with nephrotic syndrome are given. Fig. 9 The experimental results show that compared with the model group, the low, medium and high dose groups of the total saponins of leek seeds of the present invention can significantly reduce the MDA content in the kidneys of mice after administration of doxorubicin, and the medium and high dose groups can significantly increase the T-SOD enzyme activity in the kidneys. The results show that the total saponins of leek seeds of the present invention have a protective effect on oxidative damage to mouse kidney tissue, and can enhance the antioxidant function of mouse kidneys after administration, and reduce free radical damage to the kidneys.
Claims
1. A method for preparing total saponins from leek seeds, characterized in that: The leek seeds are added into ethanol for extraction, and the extraction is concentrated under reduced pressure to obtain a crude extract; the crude extract is dissolved in water, adsorbed on a macroporous adsorption resin, and then eluted with water and ethanol, the ethanol eluate is collected, and the component 1 is obtained by concentrating under reduced pressure; component 1 is dissolved in water, extracted with an organic solvent, and the aqueous phase obtained by extraction is concentrated under reduced pressure and dried.
2. The method for preparing total saponins from leek seeds as claimed in claim 1, wherein: The leek seeds are added into ethanol with a volume concentration of 5-90% for extraction, and the extraction is performed 1-5 times with an extraction time of 60-120 seconds.
3. The method for preparing total saponins from leek seeds as claimed in claim 1, wherein The crude extract was dissolved in water and then adsorbed on HPD100 macroporous adsorption resin for 8-15 hours.
4. The method for preparing total saponins from leek seeds as claimed in claim 3, wherein: Use 60-80% volume concentration of ethanol for elution.
5. The method for preparing total saponins from leek seeds as claimed in claim 4, characterized in that: Elution was performed with 2-4 BV column volumes of 65-75% ethanol at a rate of 0.4-1 BV / h.
6. The method for preparing total saponins from leek seeds as claimed in claim 1, characterized in that: The organic solvent used for extraction was ethyl acetate.
7. The total saponins of leek seeds prepared by the preparation method according to any one of claims 1 to 6.
8. Use of the total saponins of leek seeds according to claim 7 in the preparation of medicines or health products for treating nephrotic syndrome.
9. Use of the total saponins of leek seeds according to claim 7 in the preparation of medicines or health products for treating nephrotic syndrome caused by adriamycin.
10. Use of the total saponins of leek seeds according to claim 7 in the preparation of medicines or health products for protecting kidney tissue from oxidative damage.
Citation Information
Patent Citations
Chinese leek seed extractive, preparation method thereof, and application of Chinese leek seed extractive to aspect of liver protecting drug preparation
CN109276637A
